Hi GH,
The HK exchange is really about attracting Chinese investors these days as I understand. It does attract Global capital as well but I think the fact that HK is now under control of Chinese Communist Party makes it a regulatory risk. The CCP Sovereign risk massively takes the shine off listing there, particularly if that the only exchange your listed on. As a secondary listing it maybe ok for many companies.
Look, I’m no expert by any stretch but I would’ve thought the Euronext Amsterdam is the best pick followed by London. Adyen is listed on Euronext and they are a large payments company. I don’t buy the excuses in the last update on listing. Listing a company is a complex process but Karantzis and the other Board members have significant experience here. They have been on this/ looking into this listing for over 2 years. The exchanges are keen for new listings so they can be quite accommodating.
Just aside, I contacted Dr Reuter the other day as in their PR release a few months ago they said. Get registered for ancillary list for ISX value or something like that. I emailed Dr Reuter and their response was:
Hello Ben xxxxxx,
We ourselves have nothing to do with a distributor ISX Financial or secondary values. I have therefore sent your email directly to ISX and asked them to reply to you.
Kind regards
Eva
Draw from that what you will, but I haven’t heard from ISX on the matter. I’m not concerned by that but I got the feeling Dr Reuter isn’t dealing with ISX moving forward. That’s pure speculation on my part.
I just want this thing to list or at least provide a more definitive path and stick to it as opposed to fluffy carrot dangling.
